期刊文献+

糖尿病心血管多重危险因素综合防治理念再强化 被引量:12

原文传递
导出
摘要 2型糖尿病(T2DM)治疗有两层目的:其一为防止极端血糖(过高或过低)所致急性并发症;其二,更为重要的是防止或延缓大血管及微血管并发症的发生发展,提高患者生存质量,降低致残率和病死率。对于后者,血糖控制仍为治疗基础,十分必要[1];然而单纯降糖又是不够的,必须针对心血管疾病(CVD)多重危险因素进行多方面综合干预。
作者 李秀钧
出处 《中华内科杂志》 CAS CSCD 北大核心 2013年第7期551-553,共3页 Chinese Journal of Internal Medicine
  • 相关文献

参考文献22

  • 1American Diabetes Association. Standards of medical care in diabetes 2013. Diabetes Care, 2013, 36 Suppl 1 :Sll-66.
  • 2Colwell JA. Multifactorial aspects of the treatment of the type II diabetic patient. Metabolism, 1997, 46(12 Suppl 1 ):1-4.
  • 3李秀钧,董砚虎,程丽霞,柳林.糖尿病研究进展── 第16届国际糖尿病联盟大会纪要[J].中华内分泌代谢杂志,1998,14(2):72-77. 被引量:160
  • 4李秀钧.2型糖尿病防治策略的革命——从降糖治疗到全面防治心血管危险因素[J].中华内科杂志,2002,41(4):217-218. 被引量:28
  • 5Gaede P, Vedel P, Larsen N, et al. Multifactorial interventionand cardiovascular disease in patients with type 2 diabetes. N Engl J Med, 2003,348:383-393.
  • 6] Gale EA. Glucose control in the UKPDS: what did we learn? Diabet Meal,2008,25 Suppl 2:9-12.
  • 7Genuth S, Eastman R, Kahn R, et al. Implications of the United Kingdom prospective diabetes study. Diabetes Care, 2003, 26 Suppl 1 : $28-32.
  • 8Holman RR, Paul SK, Bethel MA, et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med, 2008, 359 : 1577-1589.
  • 9ADVANCE Collaborative Group, Patel A, MacMahon S, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med, 2008,358:2560-2572.
  • 10Ismail-Beigi F, Craven T, Banerji MA, et al. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet, 2010,376:419-430.

二级参考文献11

  • 1Colwell JA. Multifactorial aspects of treatment of the type 2 diabetic patient. Metabolism, 1997, 46Suppl 1: 1-4.
  • 2American Diabetes Association. Implications of the Diabetes Control and Complications Trial. Diabetes Care, 2001, 24Suppl 1: S25-27.
  • 3American Diabetes Association. Implications of the United Kingdom Prospective Diabetes Study. Diabetes Care. 2001, 24Suppl 1: S28-31.
  • 4Kahn CR, Chen L, Cohen SE. Unraveling the mechanism of action of thiazolidinediones. J Clin Invest, 2000, 106: 1305-1307.
  • 5Unger RH, Zhou YT. Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover. Diabetes, 2001, 50Suppl 1: S118-121.
  • 6Cnop M, Hannaert JC, Hoorens A, et al. Inverse relationship between cytotoxicity of fatty acids in pancneatic islet cells and cellular triglyceride accumulation. Diabetes, 2001, 50: 1771-1771.
  • 7McGarry JD. Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes, 2001, 50Suppl 2: 6-7.
  • 8Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes. Nature, 2001, 489 : 307-312.
  • 9American Diabetes Association. Aspirin therapy in diabetes. Diabetes Care, 2000, 23Suppl 1: S61-62.
  • 10American Diabetes Association. Smoking and diabetes. Diabetes Care, 2000, 23Suppl 1: S63-64.

共引文献186

同被引文献83

引证文献12

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部